Rash type (n) Demographics Demographics Immunotherapy class, n Immunotherapy class, n Immunotherapy class, n Immunotherapy class, n Rash characteristics Rash characteristics Rash characteristics Rash characteristics Other irAEs, n
Age, years, mean
Sex, n, (male, female)
Anti-PD-1
Anti-PD-L1
Anti-CTLA-4
Combined anti–PD-1 and anti–CTLA-4
Latency to irAEs, days, median (range)
Pruritus, n
Mucosal lesion, n
Blood eos, %, median (range)
Maculopapular (33) 64.8 33 (17, 16) 21 5 2 5 24.0 (0-509) 19 1 4.5 (0.4-17.1) 8
EM (2) 74.0 2 (2, 0) 2 0 0 0 94.5 (49-140) 1 0 5.2 (5.1-5.3) 0
Licehnoid (3) 67.0 3 (1, 2) 3 0 0 0 169.0 (120-255) 1 1 5.2 (3.3-7.9) 2
Psoriasiform (1) 58.0 1 (1, 0) 0 1 0 0 185.0 1 0 11.6 0
BP (1) 65.0 1 (1, 0) 1 0 0 0 231.0 1 0 3.8 0
Sclerodermoid (1) 73.0 1 (1, 0) 1 0 0 0 140.0 0 0 0.9 0
SJS (1) 69.0 1 (1, 0) 1 0 0 0 11.0 1 1 19.8 0
Total (42) 65.5 42 (24, 18) 29 6 2 5 78.9 (0-509) 24 3 5.0 (0.4-19.8) 10